Records containing: Thromboangiitis Obliterans

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-03-27
Individual Patient Expanded Access IND for Selexipag (Uptravi) in Participants With Non-healing Wound, Buerger's Disease
CLINICAL_TRIALS study record update · 2025-07-11
Multicenter Cohort Long-term Follow-up Study of Participants From Phase III Clinical Trials of Donaperminogene Seltoplasmid Injection for Critical Limb Ischemia
CLINICAL_TRIALS study record update · 2024-10-09
A Prospective, Open Label, Controlled, Randomized, Multicenter Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI) Due to Arteriosclerosis Obliterans (ASO) with a Single-arm Substudy to Assess the Safety and Potential Efficacy of CLBS12 in Patients with CLI Due to Buerger's Disease (BD)
CLINICAL_TRIALS study record update · 2016-11-10
Study of Psychological and Addictive Profile of Patients With Buerger's Disease
CLINICAL_TRIALS study record update · 2016-08-16
Treatment of Thromboangiitis Obliterans (Buerger's Disease) With Bosentan
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2016-08-12
Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia
CLINICAL_TRIALS study record update · 2016-04-19
Randomized Control Trial on Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia
CLINICAL_TRIALS study record update · 2016-03-07
Echographie de Contraste Pour l'Analyse de la Perfusion Musculaire Dans l'ischémie Critique